Development and validation of stability indicating ultra performance liquid chromatographic method for etravirine

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 1, 2012, Pages 255-261

  Ahamed, Aleem ^a   Krishnamurthy, G ^a   Bhojya Naik, H S ^a   Ramesha, S ^a  

^a KUVEMPU UNIVERSITY   (India)

Author keywords

Etravirine; Forced degradation; Validation

Indexed keywords

ACETONITRILE; ETRAVIRINE; FORMIC ACID; WATER;

ACCURACY; ARTICLE; DRUG DECOMPOSITION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG HYDROLYSIS; DRUG IMPURITY; DRUG OXIDATION; DRUG SOLUBILITY; DRUG STABILITY; ELUTION; FLOW RATE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; PH; PHOTOLYSIS; PKA; PRACTICE GUIDELINE; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TEMPERATURE; TEMPERATURE STRESS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION STUDY;

EID: 84855503830     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Das K, Clark AD, Lewi PJ, Heeres J, De Jonge MR, Koymans LM, Vinkers HM, Daeyaert F, Ludovici DW, Kukla MJ, De Corte B, Kavash RW, Ho CY, Ye H, Lichtenstein MA, Andries K, Pauwels R, De Béthune MP, Boyer PL, Clark P, Hughes SH, Janssen PA, and Arnold E: Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants. J. Med. Chem 2004; 47: 2550-2560.
2. Van Herrewege Y, Vanham G, Michiels J, Fransen K, Kestens L, Andries K, Janssen P and Lewi P: A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides, Antimicrob. Agents Chemother 2004; 48: 3684-3689
3. Mordant C, Schmitt B, Pasquier E, Demestre C, Queguiner L, Masungi C, Peeters A, Smeulders L, Bettens E, Hertogs K, Heeres J, Lewi P and Guillemont J: Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains. Eur. J. Med. Chem 2007; 42: 567-579
4. Goebel F, Yakovlev A, Pozniak AL, Vinogradova E, Boogaerts G, Hoetelmans R, de Béthune MP, Peeters M and Woodfall B: Short-term antiviral activity of TMC278--a novel NNRTI--in treatment-naive HIV-1-infected subjects. AIDS 2006; 20: 1721-1726
5. Fang C, Bauman JD, Das K, Remorino A, Arnold E and Hochstrasser RM: Two-dimensional infrared spectra reveal relaxation of the nonnucleoside inhibitor TMC278 complexed with HIV-1 reverse transcriptase. Proc Natl Acad Sci USA 2007; 105: 1472-1477
6. ICH, text on Validation of Analytical Procedures, Q2A
7. ICH Validation of Analytical Procedures, Methodology Q2B
8. References for Validation: USP 30 - NF 25
9. Abobo CV, Wu L, John J, Joseph MK, Bates TR and Liang D: LC-MS/MS determination of etravirine in rat plasma and its application in pharmacokinetic studies. J. Chromatogr B Analyt Technol Biomed Life Sci.2010; 878(30):3181-3186
10. Heine RT, Rosing H, van Gorp EC, Mulder JW, Beijnen JH and Huitema AD. J. Phar. Bio. Anal 2009; 49: 393
11. Rezk NL, White NR, Jennings SH and Kashuba AD: A novel LC-ESI-MS method for the simultaneous determination of etravirine, darunavir and ritonavir in human blood plasma. Talanta 2009; 79: 1372
12. Quaranta S, Woloch C, Paccou A, Giocanti M, Solas C and Lacarelle B: Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples. Ther Drug Monit 2009; 31: 695-702
13. D'Avolio A, Baietto L, Siccardi M, Sciandra M, Simiele M, Oddone V, Bonora S and Di Perri G: An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients. Ther Drug Monit 2008; 30: 662-669
14. Frenkel YV, Clark Jr AD, Das K, Wang YH, Lewi PJ, Janssen PAJ and Arnold E: Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailability. J. Med. Chem 2005; 48: 1974.